JP2022521956A5 - - Google Patents
Info
- Publication number
- JP2022521956A5 JP2022521956A5 JP2021549630A JP2021549630A JP2022521956A5 JP 2022521956 A5 JP2022521956 A5 JP 2022521956A5 JP 2021549630 A JP2021549630 A JP 2021549630A JP 2021549630 A JP2021549630 A JP 2021549630A JP 2022521956 A5 JP2022521956 A5 JP 2022521956A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- heavy chain
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962810771P | 2019-02-26 | 2019-02-26 | |
| US62/810,771 | 2019-02-26 | ||
| US201962811431P | 2019-02-27 | 2019-02-27 | |
| US62/811,431 | 2019-02-27 | ||
| PCT/US2020/019763 WO2020176549A1 (en) | 2019-02-26 | 2020-02-25 | Antigen binding proteins that bind bcma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022521956A JP2022521956A (ja) | 2022-04-13 |
| JP2022521956A5 true JP2022521956A5 (cg-RX-API-DMAC7.html) | 2023-01-26 |
| JP7554759B2 JP7554759B2 (ja) | 2024-09-20 |
Family
ID=72238662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549630A Active JP7554759B2 (ja) | 2019-02-26 | 2020-02-25 | Bcmaに結合する抗原結合性タンパク質 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12630642B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3930852A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7554759B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210133261A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113874082B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020228367A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021016791A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3130765A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL285813A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021010281A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202109163YA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020176549A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114650829A (zh) * | 2019-09-05 | 2022-06-21 | 索伦托药业有限公司 | 结合bcma的二聚体抗原受体(dar) |
| TWI917473B (zh) | 2020-11-02 | 2026-03-11 | 新加坡商蜂鳥生物科技私人有限公司 | Bcma/taci抗原結合分子 |
| KR20250152662A (ko) | 2020-12-31 | 2025-10-23 | 사노피 | NKp46 및 CD123에 결합하는 다기능성 자연살해(NK) 세포 관여자 |
| WO2022184082A1 (en) | 2021-03-03 | 2022-09-09 | Sorrento Therapeutics, Inc. | Antibody-drug conjugates comprising an anti-bcma antibody |
| WO2023227790A1 (en) | 2022-05-27 | 2023-11-30 | Sanofi | Natural killer (nk) cell engagers binding to nkp46 and bcma variants with fc-engineering |
| WO2023237366A1 (en) * | 2022-05-27 | 2023-12-14 | Sanofi | Anti-bcma antibodies |
| CN119841951B (zh) * | 2024-12-25 | 2025-10-14 | 厦门大学附属第一医院(厦门市第一医院、厦门市红十字会医院、厦门市糖尿病研究所) | 一种抗bcma抗体或其抗原结合片段及其制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6342220B1 (en) * | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
| GB9908533D0 (en) * | 1999-04-14 | 1999-06-09 | Novartis Ag | Organic compounds |
| US7214786B2 (en) * | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| CN1838968A (zh) * | 2003-08-08 | 2006-09-27 | 艾伯吉尼斯公司 | 针对甲状旁腺激素(pth)之抗体和其用途 |
| JP5718640B2 (ja) * | 2007-08-21 | 2015-05-13 | アムジエン・インコーポレーテツド | ヒトc−fms抗原結合性タンパク質 |
| MX2015005546A (es) * | 2012-11-13 | 2015-08-05 | Regeneron Pharma | Anticuerpos anti-receptor de procineticinas (prokr) y usos de los mismos. |
| TW201425336A (zh) | 2012-12-07 | 2014-07-01 | Amgen Inc | Bcma抗原結合蛋白質 |
| TW201632559A (zh) * | 2015-02-22 | 2016-09-16 | 索倫多醫療公司 | 結合cd137之抗體治療劑 |
| HUE057285T2 (hu) | 2015-04-13 | 2022-04-28 | Pfizer | Terápiás ellenanyagok és alkalmazásaik |
| TWI811023B (zh) * | 2015-08-17 | 2023-08-01 | 美商健生生物科技公司 | 抗bcma抗體,結合bcma及cd3之雙特異性抗原結合分子及其用途 |
| MA44254A (fr) * | 2016-02-17 | 2018-12-26 | Seattle Genetics Inc | Anticorps bcma et leur utilisation pour traiter le cancer et les troubles immunologiques |
| UA126813C2 (uk) * | 2017-08-01 | 2023-02-08 | Медімм'Юн, Ллк | Моноклональний кон’югат антитіло-лікарський засіб до bcma |
| US20200224160A1 (en) * | 2018-02-27 | 2020-07-16 | Sorrento Therapeutics, Inc. | Process for dna integration using rna-guided endonucleases |
| CN109265550B (zh) * | 2018-09-25 | 2020-09-15 | 华东师范大学 | Bcma抗体、嵌合抗原受体和药物 |
| CN114650829A (zh) * | 2019-09-05 | 2022-06-21 | 索伦托药业有限公司 | 结合bcma的二聚体抗原受体(dar) |
-
2020
- 2020-02-25 KR KR1020217030843A patent/KR20210133261A/ko not_active Withdrawn
- 2020-02-25 MX MX2021010281A patent/MX2021010281A/es unknown
- 2020-02-25 WO PCT/US2020/019763 patent/WO2020176549A1/en not_active Ceased
- 2020-02-25 EP EP20763127.6A patent/EP3930852A4/en not_active Withdrawn
- 2020-02-25 CA CA3130765A patent/CA3130765A1/en active Pending
- 2020-02-25 BR BR112021016791A patent/BR112021016791A2/pt not_active IP Right Cessation
- 2020-02-25 JP JP2021549630A patent/JP7554759B2/ja active Active
- 2020-02-25 SG SG11202109163YA patent/SG11202109163YA/en unknown
- 2020-02-25 AU AU2020228367A patent/AU2020228367A1/en not_active Abandoned
- 2020-02-25 CN CN202080031584.2A patent/CN113874082B/zh not_active Expired - Fee Related
-
2021
- 2021-08-23 IL IL285813A patent/IL285813A/en unknown
- 2021-08-25 US US17/412,089 patent/US12630642B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11524991B2 (en) | PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof | |
| US12448423B2 (en) | Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains | |
| JP7250736B2 (ja) | Bcmaおよびcd3に対する結合分子 | |
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP7397882B2 (ja) | 二重特異性抗体及びその調製方法、使用 | |
| JP2022527084A5 (cg-RX-API-DMAC7.html) | ||
| AU2016339832A1 (en) | Antibody agents specific for human CD19 and uses thereof | |
| JP2016511277A (ja) | Bcmaおよびcd3に対する結合分子 | |
| JP2016513467A5 (cg-RX-API-DMAC7.html) | ||
| RU2011145428A (ru) | АНТИТЕЛА ПРОТИВ TNF-α И ИХ ПРИМЕНЕНИЯ | |
| JP2017537082A5 (cg-RX-API-DMAC7.html) | ||
| US20250206820A1 (en) | Ilt3 and cd3 binding agents and methods of use thereof | |
| JP2022521956A (ja) | Bcmaに結合する抗原結合性タンパク質 | |
| WO2013030568A1 (en) | Caninised tumour necrosis factor antibodies and methods of using the same | |
| JP2024516098A5 (cg-RX-API-DMAC7.html) | ||
| JP7574692B2 (ja) | 二重特異性抗体 | |
| KR20250059424A (ko) | Pd-1 작용제 항체 | |
| RU2021128015A (ru) | Антигенсвязывающие белки, которые связываются с bcma | |
| WO2022003693A1 (en) | Anti-tumor necrosis factor receptor (tnfr2) antibodies and uses thereof | |
| US20240067741A1 (en) | Anti-4-1bb antibodies and methods of making and using thereof | |
| RU2841957C1 (ru) | Сконструированные антитела против il-2 | |
| EP4603509A1 (en) | Multifunctional recombinant antibody, and preparation method and use therefor | |
| WO2025128264A9 (en) | Anti-pd-1 monoclonal antibody and methods of use thereof | |
| JP2025541365A (ja) | 多価造血細胞係合因子または活性化因子 | |
| CN114025797A (zh) | 抗Gal9免疫抑制性结合分子 |